Fauci 'Satisfied' With Enrollment So Far In Moderna Coronavirus Vaccine TrialDr. Anthony Fauci said he's "satisfied" with the enrollment in the first week of the first US Phase 3 clinical trial of a Covid-19 vaccine.
Moderna Says Coronavirus Vaccine Study Should Complete Enrollment In SeptemberModerna said it's coronavirus vaccine study is on track to complete enrollment of all 30,000 volunteers by next month.
Moderna Says Cororavirus Vaccine Shows Promise In MonkeysModerna claims its’ coronavirus vaccine is showing promise in monkeys.
Moderna Begins Testing Coronavirus Vaccine On 30,000 VolunteersThe world's biggest COVID-19 vaccine test got underway Monday with the first of 30,000 planned volunteers.
First COVID-19 Vaccine Tested In US Poised For Final TestingThe first COVID-19 vaccine tested in the U.S. revved up people's immune systems just the way scientists had hoped, researchers reported Tuesday.
Moderna Set To Test Potential Coronavirus Vaccine With 30,000 VolunteersThe Cambridge biotech company said it is on track to be able to produce between 500 million to 1 billion doses by the start of 2021.
Coronavirus Vaccine: Here Are The Latest DevelopmentsResearchers say at this point, there's no way to predict how effective or long-lasting a novel coronavirus vaccine would be.
Cambridge Biotech Company Moderna Begins Second Stage Of Coronavirus Vaccine StudyCambridge biotech company Moderna is working on a coronavirus vaccine, and they have announced that the company has begun the next step in its trials. 
'Great' Results: Moderna's Potential Coronavirus Vaccine Produced Antibodies In HumansA Cambridge biotech company reported encouraging news Monday on its efforts to develop a potential coronavirus vaccine.
Cambridge's Moderna Gets FDA Fast Track Approval For Potential Coronavirus VaccineCambridge biotech company Moderna says it’s received a big boost from the FDA to fast track its development of a potential coronavirus vaccine.
Cambridge Company Gets FDA Approval To Move Potential Coronavirus Vaccine To Phase 2Cambridge biotech company Moderna says it has FDA approval to start the second phase of its development of a potential coronavirus vaccine.